Optical coherence tomography and disease subtype in multiple sclerosis
Abstract
Objective: To examine retinal nerve fiber layer (RNFL) thickness, macular volumes (MV), and visual acuity in multiple sclerosis (MS) eyes, with and without history of acute optic neuritis (ON).
Methods: RNFL thickness was measured in 326 MS and 94 control eyes using optical coherence tomography (OCT). MV and vision testing were done in a subset of the cohort. MS subtype was classified as relapsing-remitting (RRMS, n = 135), primary progressive (PPMS, n = 12), and secondary progressive (SPMS, n = 16).
Results: MS ON eyes had decreased RNFL thickness (84.2 μm) compared to controls (102.7 μm) (p < 0.0001). Unaffected fellow eyes of MS ON eyes (93.9 μm) (p < 0.01) and patients with MS with no history of ON (95.9 μm) (p < 0.05) also had decreased RNFL. RRMS (94.4 μm) (p < 0.001), PPMS (88.9 μm) (p < 0.01), and SPMS (81.8 μm) (p < 0.0001) (adjusted for age and duration of disease) had decreased RNFL compared to controls. There were significant differences in RNFL thickness within quadrants of peripapillary retina comparing relapsing to progressive MS subtypes. MV was decreased in MS ON eyes (6.2 mm3) (p < 0.0001) and SPMS subjects (6.2 mm3) (p < 0.05) compared to controls (6.8 mm3).
Conclusion: Retinal nerve fiber layer (RNFL) is significantly decreased in multiple sclerosis (MS) optic neuritis (ON) eyes, unaffected fellow eyes of patients with MS ON, and MS eyes not affected by ON in our cohort. Macular volumes (MV) showed a significant decrease in MS ON eyes. Progressive MS cases showed more marked decreases in RNFL and MV than relapsing-remitting MS. OCT is a promising tool to detect subclinical changes in RNFL and MV in patients with MS and should be examined in longitudinal studies as a potential biomarker of retinal pathology in MS.
Get full access to this article
View all available purchase options and get full access to this article.
REFERENCES
1.
Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121(Pt 1):3–24.
2.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–1452.
3.
Rudick R, Antel J, Confavreux C, et al. Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol 1997;42:379–382.
4.
Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278–285.
5.
Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120(Pt 3):393–399.
6.
Kerrison JB, Flynn T, Green WR. Retinal pathologic changes in multiple sclerosis. Retina 1994;14:445–451.
7.
Trip SA, Schlottmann PG, Jones SJ, et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 2006;31:286–293.
8.
Chen TC, Cense B, Miller JW, et al. Histologic correlation of in vivo optical coherence tomography images of the human retina. Am J Ophthalmol 2006;141:1165–1168.
9.
Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999;40:2520–2527.
10.
Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006;113:324–332.
11.
Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005;58:383–391.
12.
Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006;59:963–969.
13.
McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–127.
14.
Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neurol 2005;58:840–846.
15.
Paunescu LA, Schuman JS, Price LL, et al. Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using Stratus OCT. Invest Ophthalmol Vis Sci 2004;45:1716–1724.
16.
Guan Y, Shindler KS, Tabuena P, Rostami AM. Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice. J Neuroimmunol 2006;178:40–48.
17.
Shindler KS, Guan Y, Ventura E, Bennett J, Rostami A. Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis. Mult Scler 2006;12:526–532.
18.
Balcer LJ, Baier ML, Cohen JA, et al. Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Neurology 2003;61:1367–1373.
19.
Baier ML, Cutter GR, Rudick RA, et al. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology 2005;64:992–995.
20.
Jaffe GJ, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol 2004;137:156–169.
21.
Kanamori A, Nakamura M, Escano MF, Seya R, Maeda H, Negi A. Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol 2003;135:513–520.
22.
Medeiros FA, Zangwill LM, Bowd C, Weinreb RN. Comparison of the GDx VCC scanning laser polarimeter, HRT II confocal scanning laser ophthalmoscope, and Stratus OCT optical coherence tomograph for the detection of glaucoma. Arch Ophthalmol 2004;122:827–837.
23.
Frohman E, Costello F, Zivadinov R, et al. Optical coherence tomography in multiple sclerosis. Lancet Neurol 2006;5:853–863.
24.
Danesh-Meyer HV, Birch H, Ku JY, Carroll S, Gamble G. Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology 2006;67:1852–1854.
Information & Authors
Information
Published In
Copyright
© 2007.
Publication History
Published online: November 26, 2007
Published in print: November 27, 2007
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Assessing disease progression and treatment response in progressive multiple sclerosis, Nature Reviews Neurology, 20, 10, (573-586), (2024).https://doi.org/10.1038/s41582-024-01006-1
- Retinal changes in multiple sclerosis: An optical coherence tomography and angiography study, Revue Neurologique, 180, 7, (622-631), (2024).https://doi.org/10.1016/j.neurol.2023.11.014
- Early reduction of retinal thickness predicts physical and cognitive disability in newly diagnosed multiple sclerosis patients: results from a cross-sectional study, Neurological Sciences, (2024).https://doi.org/10.1007/s10072-024-07664-9
- Retinal optical coherence tomography measures in multiple sclerosis: a systematic review and meta‐analysis, Annals of Clinical and Translational Neurology, 11, 9, (2236-2253), (2024).https://doi.org/10.1002/acn3.52165
- Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis, International Journal of Molecular Sciences, 24, 5, (4375), (2023).https://doi.org/10.3390/ijms24054375
- Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes, Neurology, 101, 10, (e1014-e1024), (2023)./doi/10.1212/WNL.0000000000207551
- Automatic Segmentation of Retinal Layers in Multiple Neurodegenerative Disorder Scenarios, IEEE Journal of Biomedical and Health Informatics, 27, 11, (5483-5494), (2023).https://doi.org/10.1109/JBHI.2023.3313392
- Artificial Intelligence for Multiple Sclerosis Management Using Retinal Images: Pearl, Peaks, and Pitfalls, Seminars in Ophthalmology, 39, 4, (271-288), (2023).https://doi.org/10.1080/08820538.2023.2293030
- Inner and Outer Retina Findings Determined by Optical Coherence Tomography in Different Subtypes Of Multiple Sclerosis, Nigerian Journal of Clinical Practice, 25, 7, (1069-1075), (2022).https://doi.org/10.4103/njcp.njcp_1568_21
- The Usefulness of Optical Coherence Tomography in Disease Progression Monitoring in Younger Patients with Relapsing-Remitting Multiple Sclerosis: A Single-Centre Study, Journal of Clinical Medicine, 12, 1, (93), (2022).https://doi.org/10.3390/jcm12010093
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.